Plasma viscosity: accuracy, precision and suitability – who wants it?
The diagnostic and prognostic value of plasma viscosity has been highlighted in patients suspected or confirmed as having COVID-19, but its use in other areas of UK medical practice has gained clinical acceptance over the past seven decades.
This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.
ScheBo® • Biotech AG is an innovative biotech company that is active in the field of development, production and marketing of diagnostics.
The manufacturing of our leading products is matched exactly to satisfy of our customers.
ScheBo® • Biotech AG was founded by the biochemists and molecular biologists Ursula Scheefers-Borchel, Ph.D.,...